Nuvectis Pharma

1. NXP900 Ph1 interimsummer 2026NXP900 Ph1 interim, summer 2026, major
2. NXP900 Ph1 readoutby the end of this yearNXP900 Ph1 readout, by the end of this year, material
3. NXP200 Ph1 readout4Q 2026NXP200 Ph1 readout, 4Q 2026, notable
4. NXP100 China decision4Q 2026NXP100 China decision, 4Q 2026, routine
5. Haisco license agreement financingDec 22, 2026Haisco license agreement financing, Dec 22, 2026, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.